More Safety Data Would Be Nice, But We Need a Vaccine Now

On Monday, Pfizer and partner BioNTech announced data showing that their vaccine may be 90 percent effective for reducing symptomatic Covid cases. That is an astounding success, albeit preliminary. So far, after tens of thousands of vaccine recipients, there have been no serious safety concerns. The major question now becomes how soon we can safely […]